MedXY
Not signed in Sign in / Register
Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • iDoctor
  • Medical Calculators
  • Videos
  • Health Games
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • iDoctor
  • Medical Calculators
  • Videos
  • Health Games

JACC Consensus

Search medical newsFind research, conditions and clinical updates
  • Home
  • JACC Consensus
Navigating the AfMR Maze: Expert Consensus and the Future of Mitral Regurgitation Diagnosis
Posted inCardiology news

Navigating the AfMR Maze: Expert Consensus and the Future of Mitral Regurgitation Diagnosis

Posted by By MedXY 03/25/2026
This article examines the debate between JACC and ESC definitions for Atrial Functional Mitral Regurgitation (AfMR), highlighting why the JACC Expert Consensus offers a more robust framework for clinical prognosis and patient classification.
Read More
Redefining Heart Valve Disease: The Battle Over Atrial Functional Mitral Regurgitation Guidelines
Posted inCardiology Internal Medicine news

Redefining Heart Valve Disease: The Battle Over Atrial Functional Mitral Regurgitation Guidelines

Posted by By MedXY 03/21/2026
This article explores the critical differences between JACC and ESC definitions for Atrial Functional Mitral Regurgitation (AfMR), highlighting how the JACC Consensus provides a more robust prognostic framework for managing this emerging heart condition.
Read More

Take a game break

Explore a few games from MedXY.

Explore all games
  • Enhancing Walking Recovery in Chronic Stroke: The Role of Contralesional Cortico-Reticulospinal Tract Changes Following High-Intensity Locomotor Training
  • AI Versus Clinicians: Evaluating Accuracy in 10-Year Periodontal Tooth Loss Prognosis
  • Combining Endometrial Ablation with Levonorgestrel IUS to Reduce Hysterectomy in Heavy Menstrual Bleeding: Insights from the MIRA2 Trial
  • Optimizing Antibiotic Duration for Pediatric Pneumonia and Sinusitis in the Emergency Department: A Quality Improvement Success
  • Prevalence and Profile of Difficult-to-Manage and Treatment-Refractory Psoriatic Arthritis in Nordic Patients on Biologic Therapies
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!
  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular risk case report chronic kidney disease clinical trial clinical trials critical care diabetes epidemiology GLP-1 receptor agonists heart failure hepatocellular carcinoma Hypertension immunotherapy inflammation machine learning MASLD mental health Mortality multiple myeloma myocardial infarction nutrition obesity older adults oncology Pediatrics precision medicine Pregnancy prognosis public health quality of life randomized clinical trial randomized controlled trial risk stratification SGLT2 inhibitors stroke targeted therapy type 1 diabetes type 2 diabetes

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top